Protein O-glucosyltransferase 1 (POGLUT1)

The protein contains 392 amino acids for an estimated molecular weight of 46189 Da.

 

Dual specificity glycosyltransferase that catalyzes the transfer of glucose and xylose from UDP-glucose and UDP-xylose, respectively, to a serine residue found in the consensus sequence of C-X-S-X-P-C (PubMed:21081508, PubMed:21490058, PubMed:21949356, PubMed:27807076, PubMed:28775322). Specifically targets extracellular EGF repeats of protein such as CRB2, F7, F9 and NOTCH2 (PubMed:21081508, PubMed:21490058, PubMed:21949356, PubMed:27807076, PubMed:28775322). Acts as a positive regulator of Notch signaling by mediating O-glucosylation of Notch, leading to regulate muscle development (PubMed:27807076). Notch glucosylation does not affect Notch ligand binding (PubMed:21490058). Required during early development to promote gastrulation: acts by mediating O-glucosylation of CRB2, which is required for CRB2 localization to the cell membrane (By similarity). (updated: Oct. 10, 2018)

Protein identification was indicated in the following studies:

  1. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.
  2. Chu and co-workers. (2018) Quantitative mass spectrometry of human reticulocytes reveal proteome-wide modifications during maturation. Br J Haematol. 180(1), 118-133.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

Interpro domains
Total structural coverage: 0%
Model score: 100
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
dbSNP:rs11556605
DDD4
dbSNP:rs17852785
LGMDR21
DDD4

The reference OMIM entry for this protein is 615618

Protein o-glucosyltransferase 1; poglut1
Cap10-like protein, 46-kd; clp46
Ktel motif-containing protein 1; ktelc1
Rumi, drosophila, homolog of; rumi
Chromosome 3 open reading frame 9; c3orf9

DESCRIPTION

POGLUT1 is an endoplasmic reticulum (ER) O-glucosyltransferase that adds glucose moieties to serine residues in EGF (131530)-like repeats, such as those found in the transactivating NOTCH (see NOTCH1, 190198) intracellular domain (Chu et al., 2013).

CLONING

By sequencing clones obtained from transformed CD34 (142230)-positive myelodysplastic syndrome (614286) cells, followed by EST database analysis, Teng et al. (2006) identified POGLUT1, which they designated CLP46. The transcript contains 2 variant polyadenylation signals and encodes a deduced 392-amino acid protein with a calculated molecular mass of 46.2 kD. It has a 23-amino acid N-terminal signal peptide and a C-terminal KTEL motif predicted to function as an ER retention signal. It also has a highly conserved domain similar to Cryptococcus neoformans Cap10, a lipopolysaccharide capsule-associated enzyme. CLP46 orthologs are present in vertebrates, insects, and plants. Northern blot analysis detected variable expression of a major transcript of 3.5 kb and a minor transcript of 1.9 kb in most human tissues examined. Expression was high in liver, moderate in heart, spleen, kidney, lung, and peripheral blood leukocytes, and weak in brain, skeletal muscle, and placenta. Little to no expression was detected in colon, thymus, and small intestine. Epitope-tagged CLP46 colocalized with an ER marker in transfected COS-7 cells.

GENE STRUCTURE

Teng et al. (2006) determined that the POGLUT1 gene contains 11 exons and spans over 25.7 kb.

MAPPING

By genomic sequence analysis, Teng et al. (2006) mapped the POGLUT1 gene to chromosome 3q13.33.

GENE FUNCTION

Teng et al. (2006) found that expression of CLP46 was elevated in CD34-positive MDS cells compared with normal adult bone marrow. Overexpression of CLP46 increased the rate of growth in U937 monocytic leukemia cells. Using recombinant proteins, Takeuchi et al. (2011) found that both mouse and human RUMI catalyzed the transfer of glucose from UDP-glucose onto serines within an EGF repeat from human factor VII (F7; 613878). In addition, mouse, Drosophila, and human RUMI catalyzed transfer of xylose from UDP-xylose onto serines within EGF repeats. RUMI did not use UDP-glucuronic acid. EGF repeat-16 of mouse Notch2 (600275) was modified with either O-xylose or O-glucose in RUMI-transfected cells. By examining this EGF repeat, which contains a diserine motif, Takeuchi et al. (2011) determined that properly folded EGF repeats containing the O-glucose consensus sequences (CxSxPC) were O-glycosylated by RUMI, whereas EGF repeats containing a diserine (CxSSPC) permitted RUMI-dependent O-xylosylation and O-glycosylation. Mutation of the second serine caused loss of O-xylosylation, but not O-glycosylation, at this site. Epitope-tagged human RUMI rescued the sensory organ and wing phenotypes in Rumi mutant flies, suggesting a high degree of conservation. Ma et al. (2011) found that knockdown of CLP46 in human cell lines via RNA interference had a negative effect on Notch signaling and reduced cell proliferation. Knockdown of CLP46 reduced the protein level of endogenous NOTCH1 and NOTCH intracellular domain and reduced expression of direct NOTCH1 targets and downstream effectors. Reduced Notch signaling and cell proliferation were accompanied by accumulation of the cell cycle inhibitor CDKN1B (600778) and decreased phosphorylation of the CDKN1B target RB (RB1; 614041). Ma et al. (2011) conc ... More on the omim web site

Subscribe to this protein entry history

June 30, 2020: Protein entry updated
Automatic update: OMIM entry 615618 was added.

Oct. 19, 2018: Additional information
Initial protein addition to the database. This entry was referenced in Bryk and co-workers. (2017).